Clinical predictor score to identify patients at risk of poor viral load suppression at six months on antiretroviral therapy: results from a prospective cohort study in Johannesburg, South Africa

References

• United Nations Against AIDS (UNAIDS) data 2018. Available from: http://www.unaids.org/sites/default/files/media_asset/unaids-data-2018_en.pdf. Assessed April 11, 2019.
   Google Scholar
• Antiretroviral Therapy Cohort Collaboration. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV. 2017;4(8):e349–e356. doi:10.1016/S2352-3018(17)30066-8.28501495
   PubMed Web of Science ®Google Scholar
• Machtinger EL, Bangsberg DR. Seven steps to better adherence: a practical approach to promoting adherence to antiretroviral therapy. AIDS Read. 2007;17(1):43–51. Available from: https://www.ncbi.nlm.nih.gov/pubmed?cmd=historysearch&querykey=1.17274147
   PubMedGoogle Scholar
• The Fifth South African National HIV Prevalence Incidence behaviour and communication survey_ 2017.pdf. Available from: https://serve.mg.co.za/content/documents/2018/07/17/7M1RBtUShKFJbN3NL1Wr_HSRC_HIV_Survey_Summary_2018.pdf.  Accessed April 11, 2019.
   Google Scholar
• World Health Organization, Geneva, 2015 Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Available from: http://www.ncbi.nlm.nih.gov/books/NBK327115/. Accessed 6 2018.
   Google Scholar
• National Department of Health, Pretoria, South Africa 2016 National policy on hiv pre-exposure prophylaxis (PrEP) and test and treat (T&T). Accessed 26, 2019 Available from: https://sahivsoc.org/Files/PREP%20and%20TT%20Policy%20-%20Final%20Draft%20-%205%20May%202016%20(HIV%20news).pdf
   Google Scholar
• Bor J, Ahmed S, Fox MP, et al. Effect of eliminating CD4-count thresholds on HIV treatment initiation in South Africa: an empirical modeling study. PLoS One. 2017;12(6):e0178249. doi:10.1371/journal.pone.017824928617805
   PubMed Web of Science ®Google Scholar
• Stevens WS, Marshall TM. Challenges in implementing HIV load testing in South Africa. J Infect Dis. 2010;201(Suppl1):S78–S84. doi:10.1086/65038320225952
   PubMed Web of Science ®Google Scholar
• McMahon JH, Elliott JH, Bertagnolio S, Kubiak R, Jordan MR. Viral suppression after 12 months of antiretroviral therapy in low- and middle-income countries: a systematic review. Bull World Health Organ. 2013;91(5):377–385E. Available from: http://www.who.int/entity/bulletin/volumes/91/5/12-112946.pdf.23678201
   PubMed Web of Science ®Google Scholar
• Cosby CD. Hematologic disorders associated with human immunodeficiency virus and AIDS. J Infusion Nurs. 2007;30(1):22–32. doi:10.1097/00129804-200701000-00005
   Google Scholar
• Denue BA, Yusuf I, Bello HS, Abja AU, Bukar A. Changes in blood profile of human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral therapy (HAART) in North Eastern Nigeria. Journal AIDS HIV Res. 2013;5(8):284–291.
   Google Scholar
• Schreibman T, Friedland G. Use of total lymphocyte count for monitoring response to antiretroviral therapy. Clin Infect Dis. 2004;38(2):257–262. doi:10.1086/cid.2004.38.issue-214699459
   PubMed Web of Science ®Google Scholar
• Evans D, Maskew M, Fox M, et al. CD4 criteria improves the sensitivity of a clinical algorithm developed to identify viral failure in HIV-positive patients on first-line antiretroviral therapy. J Int AIDS Soc. 2014;17(1):122–123. doi:10.7448/IAS.17.1.19139
   Web of Science ®Google Scholar
• Meriki HD, Tufon KA, Afegenwi MH, et al. Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon. Infect Dis Poverty. 2014;3(1):1–11. doi:10.1186/2049-9957-3-524401663
   PubMed Web of Science ®Google Scholar
• Romanelli F, Empey K, Pomeroy C. Macrocytosis as an indicator of medication (zidovudine) adherence in patients with HIV infection. AIDS Patient Care STDS. 2002;16(9):405–411. doi:10.1089/10872910276033024512396692
   PubMed Web of Science ®Google Scholar
• Chalker JC, Andualem T, Gitau LN, et al. Measuring adherence to antiretroviral treatment in resource-poor settings: the feasibility of collecting routine data for key indicators. BMC Health Serv Res. 2010;19(10):43. doi:10.1186/1472-6963-10-43
   Web of Science ®Google Scholar
• Zetterberg E, Neuhaus J, Baker VJ, et al. Group the ISS. Platelet count kinetics following interruption of antiretroviral treatment. AIDS. 2013;29(6):997–1003.
   Google Scholar
• Nnambalirwa M, Govathson C, Evans D, McNamara L, Maskew M, Nyasulu P. Markers of poor adherence among adults with HIV attending Themba Lethu HIV Clinic, Helen Joseph Hospital, Johannesburg, South Africa. Trans R Soc Trop Med Hyg. 2016;10(12):696–704. Available from: https://academic.oup.com/trstmh/article/110/12/696/3063272.
   Web of Science ®Google Scholar
• Evans D, Fox M. When and how should we be measuring adherence to antiretroviral therapy in resource-limited settings? J Clin Res HIV AIDS Prev. 2013;1(2):24–30. Available from: http://openaccesspub.org/jcrhap/article/43.
   Google Scholar
• WHO, UNAIDS, UNICEF. Global Report: UNAIDS Report on the Global AIDS Epidemic 2013. Geneva; UNAIDS; 2013:3–5. Accessed 123 2018 Available from: http://fles.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf.
   Google Scholar
• Fox MP, Van Cutsem G, Giddy J, et al. Rates and predictors of failure of first-line antiretroviral therapy and switch to second-line ART in South Africa. J Acquir Immune Defc Syndr (1999). 2012;60(4):428. doi:10.1097/QAI.0b013e3182557785
   Web of Science ®Google Scholar
• Fox MP, Maskew M, Patrick MacPhail A, et al. Cohort profile: the Themba Lethu Clinical Cohort, Johannesburg, South Africa. Int J Epidemiol. 2013;42(2):430–439. doi:10.1093/ije/dys16722434860
   PubMed Web of Science ®Google Scholar
• Fox MP, Maskew M, Brennan AT, et al. Cohort profile: the Right to Care Clinical HIV Cohort, South Africa. BMJ Open. 2017;7(6):bmjopen-2016–015620 Available from: http://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2016-015620
   Web of Science ®Google Scholar
• National Department of Health, Pretoria, South Africa. The South African Antiretroviral Treatment Guidelines 2013. Available from: http://www.kznhealth.gov.za/medicine/2013_art_guidelines.pdf. Accessed April 11, 2019.
   Google Scholar
• Hirasen K, Evans D, Maskew M, et al. The right combination - Treatment outcomes among HIV-positive patients initiating first-line fixed-dose antiretroviral therapy in a public sector HIV clinic in Johannesburg, South Africa. Clin Epidemiol. 2017;10:17–29. Available from: https://www.dovepress.com/the-right-combination-treatment-outcomes-among-hiv-positive-patients-i-peer-reviewed-article-CLEP.29296098
   PubMed Web of Science ®Google Scholar
• Lynen L, An S, Koole O, et al. An algorithm to optimize viral load testing in HIV-positive patients with suspected first-line antiretroviral therapy failure in Cambodia. J Acquir Immune Defic Syndr. 2009;52(1):40–48. doi:10.1097/QAI.0b013e3181af670519550349
   PubMed Web of Science ®Google Scholar
• Van Griensven J, Phan V, Thai S, Koole O, Lynen L. Simplified clinical prediction scores to target viral load testing in adults with suspected first line treatment failure in Phnom Penh, Cambodia. PLoS One. 2014;9(2):878–879. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3913697&tool=pmcentrez&rendertype=abstract.
   Web of Science ®Google Scholar
• Robbins GK, Johnson KL, Chang Y, et al. Predicting Virologic Failure in an HIV Clinic. Clin Infect Dis. 2010;50;779–786. Available from: https://academic.oup.com/cid/article-lookup/doi/10.1086/650537.20121574
   PubMed Web of Science ®Google Scholar
• Messou E, Gabillard D, Moh R, et al. Anthropometric and immunological success of antiretroviral therapy and prediction of virological success in west African adults. Bull World Health Organ. 2008;86(6):435–442.18568272
   PubMed Web of Science ®Google Scholar
• Steel G, Joshi MP, Paige S Antiretroviral therapy adherence measurement and support in South Africa: initial activities from July 4 to 26, 2005. Document Number: 303431 Popline by K4Health 2005 Available from: https://www.popline.org/node/263614. Accessed 26, 2019.
   Google Scholar
• Amico KR, Fisher WA, Cornman DH, et al. Visual analog scale of ART adherence: association with 3-day self-report and adherence barriers. J Acquir Immune Defic Syndr. 2006;42(4):455–459. doi:10.1097/01.qai.0000225020.73760.c216810111
   PubMed Web of Science ®Google Scholar
• Berg KM, Arnsten JH. Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr. 2006;43(SUPPL. 1):1–16. doi:10.1097/01.qai.0000248337.97814.6616936557
   PubMed Web of Science ®Google Scholar
• Knobel H, Alonso J, Casado JL, et al. Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study. Aids. 2002;16(4):605–613. doi:10.1097/00002030-200203080-0001211873004
   PubMed Web of Science ®Google Scholar
• Famoye F, Rothe DE. Variable selection for poisson regression model. J Mod Appl Stat Methods. 2003; 2(2):380–388. Available from: http://digitalcommons.wayne.edu/jmasm/vol2/iss2/11.
   Google Scholar
• Hardin JW, Hilbe J. Generalized Linear Models and Extensions. Third press S, editor. Texas: Stata press; 2012:455.
   Google Scholar
• Seymour DG, Green M, Vaz FG. Making better decisions: construction of clinical scoring systems by the Spiegelhalter-Knill-Jones approach. BMJ. 1990;300(6719):223–226. doi:10.1136/bmj.300.6719.2232106929
   PubMed Web of Science ®Google Scholar
• Stata Corps. STATA 13 Software. Stata Statistical Software. College Station, TX: StataCorpLP; 2013.
   Google Scholar
• Badri M, Cleary S, Maartens G, et al. When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study. Antivir Ther. 2006;11(1):63–72.16518961
   PubMed Web of Science ®Google Scholar
• Segeral O, Madec Y, Ban B, et al. Simplified assessment of antiretroviral adherence and prediction of virological efficacy in HIV-infected patients in Cambodia. AIDS Res Treat. 2010;2010:142076. doi:10.1155/2010/14207621490902
   PubMedGoogle Scholar
• Colebunders R, Moses KR, Laurence J, et al. A new model to monitor the virological efficacy of antiretroviral treatment in resource poor countries. Lancet Infect Dis. 2006;6(1):53–59. Available from. doi:10.1016/S1473-3099(05)70327-316377535
   PubMed Web of Science ®Google Scholar
• Abouyannis M, Menten J, Kiragga A, et al. Development and validation of systems for rational use of viral load testing in adults receiving first-line ART in sub-Saharan Africa. AIDS. 2011;25(13):1627–1635. Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00002030-201108240-00008.
   Google Scholar
• Narainsamy D, Mahomed S. Delays in switching patients onto second-line antiretroviral treatment at a public hospital in eThekwini, KwaZulu-Natal. South Afr J HIV Med. 2017;18(1):696 Available from:: http://www.sajhivmed.org.za/index.php/hivmed/article/view/696.29568632
   PubMed Web of Science ®Google Scholar
• Chimukangara B, Kharsany ABM, Lessells RJ, et al. Moderate-to-high levels of pretreatment HIV drug resistance in KwaZulu-Natal Province, South Africa. AIDS Res Hum Retroviruses. 2019;35(2):129–138. doi:10.1089/AID.2018.020230430843
   PubMed Web of Science ®Google Scholar